Safety and Efficacy of Oral BT-11 in Crohn's Disease Patients With Moderate to Severe Disease

NCT05057273 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Decision by Landos Biopharma (not related to safety or efficacy)

Conditions

Crohn's Disease

Interventions

DRUG: BT-11
DRUG: Active comparator

Sponsor

NImmune Biopharma